News

The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes ...
Pfizer’s second quarter results were well received by the market, as the company outperformed Wall Street’s expectations for ...
Pfizer CEO says drugmakers ‘are all ready to roll up their sleeves and execute’ as president demands more direct-to-consumer ...
A declining stock price amid steadily rising payouts means Realty Income stock offers an above-average yield of 5.5% at ...
The biotech industry needs to be supported by the government, by Congress,” Pfizer’s Albert Bourla told investors Tuesday in ...
While Pfizer CEO Albert Bourla, Ph.D., said he couldn’t reveal many details, he noted that Pfizer is in “very active discussions” around most favored nation drug pricing.
CEO says pharma executives discussed Trump's call to launch DTC initiatives under his Most Favored Nation policy to lower U.S ...
Pfizer (NYSE: PFE) is a case in point, with its forward dividend yield of 7%. Although the stock is a favorite for many ...
We recently published 10 Stocks Jim Cramer Discussed As He Questioned Official Data. Pfizer Inc. (NYSE:PFE) is one of the ...
Chief Executive Albert Bourla says he is hopeful about finding a solution in response to Trump’s demand for price cuts.
Bourla, who took over as CEO in 2019, has declined to say how long he intends to remain in his role at Pfizer. Developing a ...